Cargando…

Re: Non-progressive breast carcinomas detected at mammography screening: a population study—a model test or a novel test of cancer regression?

Detalles Bibliográficos
Autor principal:	Zahl, Per-Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512477/ https://www.ncbi.nlm.nih.gov/pubmed/37730664 http://dx.doi.org/10.1186/s13058-023-01708-2

Ejemplares similares

Breast cancer mortality in organised mammography screening in Denmark: comparative study
por: Jørgensen, Karsten Juhl, et al.
Publicado: (2010)

Overdiagnosis in organised mammography screening in Denmark. A comparative study
por: Jørgensen, Karsten J, et al.
Publicado: (2009)

Non-progressive breast carcinomas detected at mammography screening: a population study
por: Heggland, Torunn, et al.
Publicado: (2023)

Effect of mammography screening on surgical treatment for breast cancer in Norway: comparative analysis of cancer registry data
por: Suhrke, Pål, et al.
Publicado: (2011)

‘Test, re-test, re-test’: using inaccurate tests to greatly increase the accuracy of COVID-19 testing
por: Ramdas, Kamalini, et al.
Publicado: (2020)

Response to: COVID-related upsurge in diagnoses of advanced breast cancer—is a disruption in mammography screening the one to be blamed?
por: Toss, A.
Publicado: (2021)

The detectability of breast cancer by screening mammography.
por: Ciatto, S., et al.
Publicado: (1995)

Re: Molecular testing to deliver personalised chemotherapy recommendations
por: Gibbs, Peter, et al.
Publicado: (2023)

Breast Cancer Detection in a Screening Population: Comparison of Digital Mammography, Computer-Aided Detection Applied to Digital Mammography and Breast Ultrasound
por: Cho, Kyu Ran, et al.
Publicado: (2016)

Breast carcinoma detection modes and death in a female population in relation to population-based mammography screening
por: Sarkeala, Tytti, et al.
Publicado: (2014)

Re: Clinical experience across the fetal‐fraction spectrum of a non‐invasive prenatal screening approach with low test‐failure rate
por: Jelsema, R., et al.
Publicado: (2020)

RE: The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa
por: Mansani, Fabio Postiglione, et al.
Publicado: (2022)

The predictive value of positive test results in screening for breast cancer by mammography in the Nijmegen programme.
por: Peeters, P. H., et al.
Publicado: (1987)

The importance of COVID-19 screening and testing in the obstetric patient population
por: Hoyler, Marguerite M., et al.
Publicado: (2020)

Re-visiting preoperative SARS-CoV-2 testing using a Bayesian approach
por: Yang, Stephen Su, et al.
Publicado: (2020)

Comment on 'Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis'
por: Zhu, Min, et al.
Publicado: (2018)

Reply to ‘Comment on ‘Addition of ultrasound to mammography in the case of dense breast tissue: systematic review and meta-analysis”
por: Rebolj, Matejka, et al.
Publicado: (2018)

Deep Learning to Improve Breast Cancer Detection on Screening Mammography
por: Shen, Li, et al.
Publicado: (2019)

Bilateral breast Rosai‐Dorfman disease screen detected by mammography
por: Sumner, Christina, et al.
Publicado: (2023)

Adjusting the incidence increase when screening for statistical lead time will always give estimates of overdiagnosis close to zero
por: Zahl, Per-Henrik
Publicado: (2014)

Change in effectiveness of mammography screening with decreasing breast cancer mortality: a population-based study
por: Christiansen, Søren R, et al.
Publicado: (2022)

Re-attendance after false-positive screening mammography: a population-based study in the Netherlands
por: Setz-Pels, W, et al.
Publicado: (2013)

Mammography in Breast Disease Screening and Diagnosis
por: Tari, Daniele Ugo, et al.
Publicado: (2023)

Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands
por: van Breest Smallenburg, V, et al.
Publicado: (2013)

RE: The WISDOM Personalized Breast Cancer Screening Trial: Simulation Study to Assess Potential Bias and Analytic Approaches
por: Carter, Kimbroe, et al.
Publicado: (2020)

AI in breast screening mammography: breast screening readers' perspectives
por: de Vries, Clarisse Florence, et al.
Publicado: (2022)

The Effects of Prior Mammography Screening on the Performance of Breast Cancer Detection in Taiwan
por: Chang, Chin-Chuan, et al.
Publicado: (2022)

Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study
por: Singh, Deependra, et al.
Publicado: (2016)

Testing COVID-19 therapies to prevent progression of mild disease
por: Lipsitch, Marc, et al.
Publicado: (2020)

RE: Low-Dose Aspirin in High-Risk Individuals With Screen-Detected Subsolid Lung Nodules: A Randomized Phase II Trial
por: Braillon, Alain
Publicado: (2021)

Breast cancer incidence and menopausal hormone therapy in Norway from 2004 to 2009: a register-based cohort study
por: Suhrke, Pål, et al.
Publicado: (2015)

Border screening is an essential component of COVID-19 testing strategies in Vanuatu
por: van Gemert, Caroline, et al.
Publicado: (2021)

Utility of flow cytometry screening before MRD testing in multiple myeloma
por: Panakkal, Vandana, et al.
Publicado: (2023)

Estimating Distributions of Breast Cancer Onset and Growth in a Swedish Mammography Screening Cohort
por: Strandberg, Rickard, et al.
Publicado: (2022)

An investigation of the apparent breast cancer epidemic in France: screening and incidence trends in birth cohorts
por: Junod, Bernard, et al.
Publicado: (2011)

Characteristics of breast cancers detected by screening mammography in Taiwan: a single institute’s experience
por: Han, Hsin-Ju, et al.
Publicado: (2023)

Artificial Intelligence Improves Detection of Supplemental Screening Ultrasound-detected Breast Cancers in Mammography
por: Yoen, Heera, et al.
Publicado: (2023)

Modern mammography screening and breast cancer mortality: population study
por: Weedon-Fekjær, Harald, et al.
Publicado: (2014)

Is oropharyngeal sampling a reliable test to detect SARS-CoV-2?
por: Todsen, Tobias, et al.
Publicado: (2021)

Bias in Observational Studies of the Association between Menopausal Hormone Therapy and Breast Cancer
por: Zahl, Per-Henrik, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_he81dl00kbfh0gptbgidm3q2es